HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 185 filers reported holding HORIZON PHARMA PLC in Q4 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $354,000 | +14.9% | 21,400 | -1.4% | 0.07% | +16.1% |
| Q1 2018 | $308,000 | -37.4% | 21,700 | -35.6% | 0.06% | -38.0% |
| Q4 2017 | $492,000 | -71.0% | 33,700 | -74.8% | 0.10% | -70.8% |
| Q3 2017 | $1,695,000 | -41.2% | 133,700 | -44.9% | 0.34% | -42.0% |
| Q2 2017 | $2,885,000 | -0.3% | 242,700 | +24.0% | 0.59% | -0.2% |
| Q1 2017 | $2,894,000 | +22.8% | 195,778 | +34.4% | 0.59% | +7.4% |
| Q4 2016 | $2,357,000 | -32.3% | 145,700 | -24.1% | 0.55% | -30.1% |
| Q3 2016 | $3,481,000 | +28.5% | 191,850 | +16.7% | 0.79% | +15.7% |
| Q2 2016 | $2,708,000 | -0.6% | 164,400 | 0.0% | 0.68% | -0.4% |
| Q1 2016 | $2,724,000 | +1155.3% | 164,400 | +1544.0% | 0.68% | +1143.6% |
| Q4 2015 | $217,000 | +9.6% | 10,000 | 0.0% | 0.06% | +12.2% |
| Q3 2015 | $198,000 | – | 10,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,018,021 | $44,063,000 | 7.20% |
| SCOPIA CAPITAL MANAGEMENT LP | 16,370,364 | $239,007,000 | 4.29% |
| JW Asset Management, LLC | 270,775 | $3,953,000 | 4.21% |
| Avoro Capital Advisors LLC | 4,436,183 | $64,768,000 | 4.20% |
| Rhenman & Partners Asset Management AB | 1,954,912 | $28,542,000 | 3.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,341,894 | $92,592,000 | 3.64% |
| Paulson & Co. | 7,870,700 | $114,912,000 | 2.24% |
| Proxima Capital Management, LLC | 260,000 | $3,796,000 | 2.20% |
| KOPP INVESTMENT ADVISORS LLC | 105,126 | $1,535,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 1,000,000 | $14,600,000 | 1.46% |